HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Free Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Stigliano, A Articles by Toscano, V Search for Related Content PubMed PubMed Citation Articles by Stigliano, A Articles by Toscano, V

¹ Endocrinology, II Faculty of Medicine, S Andrea Hospital, ‘Sapienza’ University of Rome, 00189 Rome, Italy² Research Center, S Pietro Hospital, Rome, Italy³ Diagnostica Molecolare Avanzata, II Faculty of Medicine, S Andrea Hospital, ‘Sapienza’ University of Rome, 00189 Rome, Italy

(Correspondence should be addressed to A Stigliano Endocrinology, II Faculty of Medicine, Research Center, ‘Sapienza’ University of Rome, 00189 Rome, Italy; Email: antonio.stigliano{at}uniroma1.it)

Mitotane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chloro-phenyl) ethane (o,p'-DDD), is a compound that represents the effective agent in the treatment of the adrenocortical carcinoma (ACC), able to block cortisol synthesis. In this type of cancer, the biological mechanism induced by this treatment remains still unknown. In this study, we have already shown a greater impairment in the first steps of the steroidogenesis and recognized a little effect on cell cycle. We also evaluated the variation of proteomic profile of the H295R ACC cell line, either in total cell extract or in mitochondria-enriched fraction after treatment with mitotane. In total cell extracts, triose phosphate isomerase, -enolase, D-3-phosphoglycerate dehydrogenase, peroxiredoxin II and VI, heat shock protein 27, prohibitin, histidine triad nucleotide-binding protein, and profilin-1 showed a different expression. In the mitochondrial fraction, the following proteins appeared to be down regulated: aldolase A, peroxiredoxin I, heterogenous nuclear ribonucleoprotein A2/B1, tubulin-β isoform II, heat shock cognate 71 kDa protein, and nucleotide diphosphate kinase, whereas adrenodoxin reductase, cathepsin D, and heat shock 70 kDa protein 1A were positively up-regulated. This study represents the first proteomic study on the mitotane effects on ACC. It permits to identify some protein classes affected by the drug involved in energetic metabolism, stress response, cytoskeleton structure, and tumorigenesis.

This article has been cited by other articles:

				A. B. Siva, D. B. Kameshwari, V. Singh, K. Pavani, C. S. Sundaram, N. Rangaraj, M. Deenadayal, and S. Shivaji Proteomics-based study on asthenozoospermia: differential expression of proteasome alpha complex Mol. Hum. Reprod., July 1, 2010; 16(7): 452 - 462. [Abstract] [Full Text] [PDF]

				M. C. Zatelli, E. Gentilin, F. Daffara, F. Tagliati, G. Reimondo, G. Carandina, M. R. Ambrosio, M. Terzolo, and E. C. degli Uberti Therapeutic Concentrations of Mitotane (o,p'-DDD) Inhibit Thyrotroph Cell Viability and TSH Expression and Secretion in a Mouse Cell Line Model Endocrinology, June 1, 2010; 151(6): 2453 - 2461. [Abstract] [Full Text] [PDF]

				P. Hadji, M. Ziller, D. G. Kieback, W. Dornoff, H. W. Tessen, T. Menschik, J. Kuck, F. Melchert, and A. Hasenburg Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy Ann. Onc., July 1, 2009; 20(7): 1203 - 1209. [Abstract] [Full Text] [PDF]

				G. V. Shah, A. Muralidharan, S. Thomas, M. Gokulgandhi, M. Mudit, M. Khanfar, and K. El Sayed Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis Mol. Cancer Ther., March 1, 2009; 8(3): 509 - 520. [Abstract] [Full Text] [PDF]